HEALTH● LOW1d ago · Oct 12, 2026, 9:16 PM
J&J long-term Tremfya data demonstrates Crohn's remission through three years
Seeking Alpha Tech · global
Long-term data for J&J's drug Tremfya shows sustained remission for Crohn's disease patients over three years. This represents a significant positive development in the treatment of Crohn's disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH54m agoAt NIFST AGM: NAFDAC DG charges food scientists on food safety, qualityVanguard NigeriaHEALTH1h agoAMR: FG warns of growing threat of drug-resistant infectionsVanguard NigeriaHEALTH1h agoUttar Pradesh MBBS doctors protest over pay disparity, pending salary arrears; announce work boycottThe HinduHEALTH1h agoDoctors discuss Pope Leo's lung cancer diagnosisCBS News